1 research outputs found
Prediction of cognition in Parkinson's disease with a clinicalâgenetic score: a longitudinal analysis of nine cohorts
International audienceSummary Background Cognitive decline is a debilitating manifestation of disease progression in Parkinsonâs disease. We aimed to develop a clinical-genetic score to predict global cognitive impairment in patients with the disease. Methods A prediction algorithm for global cognitive impairment (defined as Mini Mental State Exam (MMSE) â€25) was built using data from 1,350 patients with 5,165 longitudinal visits over 12.8 (median, 2.8) years. Age at onset, MMSE, education, motor exam score, gender, depression and GBA mutations, machine selected through stepwise Coxâ hazards analysis and Akaikeâs information criterion, were used to compute the multivariable predictor. Independent validation was achieved in another 1,132 patients with 19,127 visits over 8.6 (median, 6.5) years. Findings The cognitive risk score accurately predicted cognitive impairment within ten years of disease onset with an area under the curve (AUC) of >0.85 in both the discovery (95% CI, 0.821â0.902) and validation populations (95% CI, 0.779 â 0.913). 72.6% of patients scoring in the highest quartile were cognitively impaired by ten years vs. 3.7% in the lowest quartile (hazard ratio, 18.4, 95% CI, 9.4 â 36.1). Dementia or disabling cognitive impairment was predicted with an AUC of 0.877 (95% CI 0.788â0.943) and high negative predictive value (0.920, 95% 0.877â0.954) at the predefined cutoff (0.196). Performance was stable in 10,000 randomly resampled subsets. Interpretation Our predictive algorithm provides a potential test for future cognitive health or impairment in patients with Parkinsonâs. It could improve trials of cognitive interventions and inform on prognosis